Ketalar

Par Pharmaceutical, Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 27, 2026
Approval ID: 14e8f864-8b8a-4e7e-8439-e510d3107063
Products: 3 registered
Version: 33

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use KETALAR safely and effectively. See full prescribing information for KETALAR. KETALAR (ketamine hydrochloride) injection, for intravenous or intramuscular use, CIII Initial U.S. Approval: 1970

Quick Stats

Total Products3

Labelers3

Label Sections40

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.